Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android


  • Pancreatic adenocarcinoma (c), pancreaticoduodenectomy (a), distal pancreatectomy with splenectomy (c)

  • Cystic pancreatic lesions including IPMN (c), spleen-sparing distal pancreatectomy

  • Pancreatic neuroendocrine tumors (c)

  • Pancreatitis (c), pancreatic debridement (c)

  • Pancreatic pseudocyst, drainage of pancreatic pseudocyst (c)

  • Chronic pancreatitis (a), operative management of chronic pancreatitis (a), total pancreatectomy (a)

  • Peri-ampullary tumors, ampullary resection for tumor (a)

  • Pancreas divisum (a), transduodenal sphincteroplasty

  • Bile duct injury (c), choledochoenteric anastomosis (a)

  • Choledochal cyst (c)

  • Gallbladder polyps and cancer (c), gallbladder cancer operation (a)

  • Cholangiocarcinoma, hepatic segmentectomy/lobectomy (a)

  • Liver lesions (c), hepatic biopsy (c)

  • Hepatic abscess (c), hepatic abscess drainage (c)

  • Primary sclerosing cholangitis (a)

  • Hematologic diseases of the spleen (c), splenectomy (c)

  • Splenic abscess, cysts, and neoplasms (c)


  • - Don’t forget to stage in the cancer scenarios.

  • - Always mention that you will discuss cancer patients at a multidisciplinary tumor board.

(c) = core topic (a) = advanced topic

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.